STOCK TITAN
  1. Home
  2. Sec-filings
  3. LDOS
  4. [Form 4] Leidos Holdings, Inc. Insider Trading Activity

Leidos (NYSE: LDOS) director granted shares and options in equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Leidos Holdings director Patrick M. Shanahan reported routine equity compensation. On May 8, 2026, he received a grant of 1,067 shares of Leidos common stock at no cost, increasing his direct holdings to 5,762 shares.

He was also granted a stock option covering 1,281 shares of common stock at an exercise price of $131.26 per share. According to the footnote, this option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the company’s next annual stockholder meeting.

Positive

  • None.

Negative

  • None.
Insider Shanahan Patrick M
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 1,281 $0.00 --
Grant/Award Common Stock 1,067 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 1,281 shares (Direct, null); Common Stock — 5,762 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares granted 1,067 shares Common stock award on May 8, 2026
Shares held after grant 5,762 shares Direct common stock holdings after May 8, 2026 award
Option grant size 1,281 shares Stock Option (Right to Buy) granted May 8, 2026
Option exercise price $131.26/share Exercise price for 1,281-share stock option
Option expiration May 7, 2033 Expiration date of stock option grant
Stock Option (Right to Buy) financial
"He was also granted a stock option covering 1,281 shares of common stock at an exercise price of $131.26 per share."
exercise price financial
"a stock option covering 1,281 shares of common stock at an exercise price of $131.26 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"this option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the company’s next annual stockholder meeting"
annual meeting of the stockholders financial
"on the earlier of the first anniversary of the grant date or the conclusion of the company’s next annual stockholder meeting"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shanahan Patrick M
(Last)(First)(Middle)
1750 PRESIDENTS STREET
(Street)
RESTON VIRGINIA 20190
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/08/2026A1,067A$05,762D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$131.2605/08/2026A1,28105/08/2027(1)05/07/2033Common Stock1,281$01,281D
Explanation of Responses:
1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.
Remarks:
/s/ Ramune M. Kligys by PoA of Patrick M. Shanahan05/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Leidos (LDOS) director Patrick Shanahan report on this Form 4?

He reported receiving routine equity compensation, including 1,067 shares of Leidos common stock and a stock option for 1,281 shares, both granted on May 8, 2026 as part of his director compensation.

How many Leidos (LDOS) shares does Patrick Shanahan hold after this Form 4?

After the reported grant, Patrick Shanahan directly holds 5,762 shares of Leidos common stock. This reflects the addition of 1,067 newly granted shares, which were awarded at no purchase price as part of his compensation.

What are the key terms of Patrick Shanahan’s new Leidos stock option?

He received a stock option for 1,281 shares of Leidos common stock with an exercise price of $131.26 per share. The option vests in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholder meeting.

When do Patrick Shanahan’s new Leidos options vest and become exercisable?

The options vest and become exercisable in full on the earlier of the first anniversary of the May 8, 2026 grant date or the date the next annual meeting of Leidos stockholders is concluded, as specified in the Form 4 footnote.

Is Patrick Shanahan’s Leidos Form 4 a market purchase or sale of LDOS shares?

No, the Form 4 reflects compensation-related awards, not open-market trades. It shows a grant of 1,067 common shares and a stock option for 1,281 shares, both recorded at zero purchase price rather than a market transaction.